Document is current
Any future updates will be listed below
-
Authors
Peña-Hernández, Mario A.
Alfajaro, Mia Madel
Filler, Renata B.
Moriyama, Miyu http://orcid.org/0000-0003-0310-9047
Keeler, Emma L.
Ranglin, Zara E. http://orcid.org/0009-0005-0479-7728
Kong, Yong http://orcid.org/0000-0002-2881-5274
Mao, Tianyang http://orcid.org/0000-0001-9251-8592
Menasche, Bridget L. http://orcid.org/0000-0003-3520-2422
Mankowski, Madeleine C. http://orcid.org/0000-0002-8640-174X
Zhao, Zhe http://orcid.org/0000-0002-4119-0504
Vogels, Chantal B. F. http://orcid.org/0000-0003-0027-6480
Hahn, Anne M. http://orcid.org/0000-0003-0710-6775
Kalinich, Chaney C. http://orcid.org/0000-0001-9675-0065
Zhang, Shuo
Huston, Nicholas
Wan, Han
Araujo-Tavares, Rafael http://orcid.org/0000-0003-0278-1528
Lindenbach, Brett D.
Homer, Robert
Pyle, Anna Marie http://orcid.org/0000-0001-9045-8872
Martinez, David R.
Grubaugh, Nathan D. http://orcid.org/0000-0003-2031-1933
Israelow, Benjamin http://orcid.org/0000-0002-1308-8246
Iwasaki, Akiko http://orcid.org/0000-0002-7824-9856
Wilen, Craig B. http://orcid.org/0000-0003-2495-9403
-
Funding
Funding for this research was provided by:
Burroughs Wellcome Fund
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (5T32HL007974)
- License Information
-
More Information
Article History
Received: 17 April 2023
Accepted: 19 June 2024
First Online: 29 July 2024
Competing interests
: A.I. serves as a consultant for RIGImmune, Xanadu Bio, Paratus Bio and Invisishield, and serves on the Board of Directors for Roche Holdings Ltd. A.I. is an investigator of the Howard Hughes Medical Institute. C.B.W. is on the Scientific Advisory Board for ExcepGen. The remaining authors declare no competing interests.
